According to Verona Pharma's latest financial reports the company's total assets are $0.30 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.30 B | 18.75% |
2022-12-31 | $0.25 B | 39.06% |
2021-12-31 | $0.18 B | -8.63% |
2020-12-31 | $0.20 B | 176.93% |
2019-12-31 | $73.73 M | -38.75% |
2018-12-31 | $0.12 B | -26.36% |
2017-12-31 | $0.16 B | 132.54% |
2016-12-31 | $70.3 M | 308.43% |
2015-12-31 | $17.21 M | -45.89% |
2014-12-31 | $31.81 M | 357.37% |
2013-12-31 | $6.95 M | -4.98% |
2012-12-31 | $7.32 M | -27.74% |
2011-12-31 | $10.13 M | 16.28% |
2010-12-31 | $8.71 M | -30.18% |
2009-12-31 | $12.47 M | 42.57% |
2008-12-31 | $8.75 M | -27.04% |
2007-12-31 | $11.99 M | -21.36% |
2006-12-31 | $15.25 M | 420.36% |
2005-12-31 | $2.93 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.27 M | -99.91% | Bahamas |
NRC Health
NRC | $0.12 B | -60.26% | ๐บ๐ธ USA |